Attached files
file | filename |
---|---|
EX-10.21 - EXHIBIT 10.21 - SEELOS THERAPEUTICS, INC. | apri123116ex1021.htm |
EX-99.2 - EXHIBIT 99.2 - SEELOS THERAPEUTICS, INC. | apri123116ex992.htm |
EX-32.1 - EXHIBIT 32.1 - SEELOS THERAPEUTICS, INC. | apri123116ex321.htm |
EX-31.1 - EXHIBIT 31.1 - SEELOS THERAPEUTICS, INC. | apri123116ex311.htm |
EX-23.1 - EXHIBIT 23.1 - SEELOS THERAPEUTICS, INC. | apri12312016ex231bdo.htm |
EX-10.22 - EXHIBIT 10.22 - SEELOS THERAPEUTICS, INC. | apri123116ex1022.htm |
EX-10.2 - EXHIBIT 10.20 - SEELOS THERAPEUTICS, INC. | apri123116ex1020.htm |
10-K - APRI 12.31.16 10-K - SEELOS THERAPEUTICS, INC. | apri12311610k.htm |
Exhibit 21
SUBSIDIARIES OF APRICUS BIOSCIENCES, INC.
1. | NexMed (U.S.A.), Inc., incorporated in Delaware on June 18, 1997. |
2. | Apricus Pharmaceuticals USA, Inc. (formerly Topotarget USA, Inc.), incorporated in Delaware on July 12, 2006 and acquired by Apricus Biosciences, Inc. on December 29, 2011. |
3. | NexMed Holdings, Inc., incorporated in Delaware on February 28, 1997. |
4. | NexMed International Limited, incorporated in the British Virgin Islands on August 2, 1996. |